Status:
COMPLETED
Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden
Lead Sponsor:
University of Pittsburgh
Conditions:
Soft Tissue Sarcoma
Eligibility:
All Genders
18+ years
Brief Summary
Assessments (survey data) in this study are designed to sample the symptom burden of patients undergoing adjuvant and neoadjuvant chemotherapy in the hospital. There will be no change in the treatment...
Eligibility Criteria
Inclusion
- Patients who are receiving doxorubicin plus ifosfamide (AI)
Exclusion
- There is no exclusion criteria
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT01136824
Start Date
June 1 2010
End Date
May 1 2014
Last Update
July 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh, Hillman Cancer Center
Pittsburgh, Pennsylvania, United States, 15232